ARTICLE | Politics & Policy
FDA to discuss thromboxane receptor antagonists
November 19, 2010 2:00 AM UTC
FDA's Cardiovascular and Renal Drugs Advisory Committee will meet on Dec. 8 to discuss the design of clinical studies for thromboxane receptor antagonists to prevent cardiovascular events in patients ...